Cardiva Medical has appointed Charles Maroney as president, CEO and member of the company’s board of directors, effective immediately.
Maroney succeeds Rick Anderson, who has served as interim CEO since March, when the company’s Founder and CEO Augustine Lien had resigned and Glen Foy gave up his post as president to become the new CEO of Innovative Energy. Anderson will remain in his role as chairman of the board.
According to Cardiva, Maroney most recently held the position of CEO at CardioMind, a company he joined in 2006 to develop a stent delivery system to treat coronary, neuro and peripheral artery disease. Prior to CardioMind, he was president and CEO of Coalescent Surgical, a development and sales company focused on blood vessel anastomoses. Coalescent was acquired by Medtronic in 2005. Before Coalescent, Maroney was president and CEO of Prograft Medical, a stent graft technology company that he founded. Prograft was purchased by WL Gore and Associates in 1997.
Cardiva of Mountain View, Calif., also said it completed financing that is directed to bring the company’s next generation product to market.